HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 1809144)

Published in Clin Exp Immunol on September 01, 2004

Authors

S Resino1, I Galán, A Pérez, J A León, E Seoane, D Gurbindo, M Angeles Muñoz-Fernandez

Author Affiliations

1: Immunobiology Molecular Laboratory, Hospital General Universitario Gregorio Maranón Madrid, Spain.

Articles citing this

Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy. Clin Exp Immunol (2007) 1.55

Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr (2010) 1.24

Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS (2008) 1.13

Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy. BMC Infect Dis (2006) 0.89

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy. BMC Infect Dis (2006) 0.87

Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment. Clin Dev Immunol (2012) 0.86

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. J Acquir Immune Defic Syndr (2009) 0.85

CD8+ T-cell interleukin-7 receptor alpha expression as a potential indicator of disease status in HIV-infected children. PLoS One (2008) 0.82

Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus-1 (HIV-1) infected pediatric patients: a cross-sectional study. AIDS Res Ther (2007) 0.77

Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression? Clin Exp Immunol (2011) 0.76

CD31 Expression on CD4+ Cells: A Simple Method for Quantitation of Recent Thymus Emigrant CD4 Cells. Am J Trop Med Hyg (2016) 0.75

Articles cited by this

Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 5.08

Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92

HIV induces thymus depletion in vivo. Nature (1993) 3.73

Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest (1988) 3.59

Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81

The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol (2000) 2.52

Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol (1996) 2.24

Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73

Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention. MMWR Recomm Rep (1998) 1.60

Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature (1993) 1.56

Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J (2003) 1.54

T-cell regeneration: all repertoires are not created equal. Immunol Today (1997) 1.53

Thymic output: a bad TREC record. Nat Immunol (2003) 1.50

Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry (1996) 1.41

The organization of mature T-cell pools. Immunol Today (1998) 1.34

TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS (1994) 1.29

Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol (1986) 1.28

CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS (1996) 1.18

Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.15

Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry (1996) 1.14

Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS (2002) 1.14

Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS (1991) 1.11

Cytokine patterns during the progression to AIDS. Science (1994) 1.11

Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. AIDS (1999) 1.08

Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immunol Methods (2000) 1.08

Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Pediatr Infect Dis J (1997) 1.01

Immune function and phenotype before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (1999) 1.01

B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol (1991) 1.00

CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol (2000) 0.99

Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure. Clin Exp Immunol (2002) 0.97

Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol (2001) 0.96

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses (2001) 0.95

Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS. AIDS (1998) 0.92

Elevation of IgE in HIV-infected children and its correlation with the progression of disease. J Allergy Clin Immunol (1995) 0.91

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections. J Pediatr (2000) 0.89

Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study. Clin Infect Dis (2003) 0.88

Viral phenotype affects the thymic production of new T cells in HIV-1-infected children. AIDS (2001) 0.88

HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1994) 0.88

Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects. Clin Exp Immunol (1999) 0.87

Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2001) 0.85

Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res (1996) 0.85

Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected children. AIDS (2002) 0.84

Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months. HIV Med (2003) 0.84

Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy. Scand J Immunol (2000) 0.82

The predictive value of several markers in the progression to acquired immunodeficiency syndrome. Clin Chem Lab Med (1998) 0.81

Aeroallergen-specific IgE changes in individuals with rapid human immunodeficiency virus disease progression. Ann Allergy Asthma Immunol (1997) 0.81

Interleukin-6 synthesis and IgE overproduction in children with perinatal human immunodeficiency virus-type 1 infection. Ann Allergy Asthma Immunol (1999) 0.80

Differential responses of T cell subsets: possible role in the immunopathogenesis of AIDS. AIDS (2000) 0.79

Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis (2000) 0.79

Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children. AIDS (2002) 0.78

Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments. Acta Paediatr (2002) 0.77

Articles by these authors

Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol (1998) 3.10

Competition between two species for two complementary or substitutable resources. J Theor Biol (1975) 2.20

[Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice]. Aten Primaria (1997) 2.04

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81

Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth (2006) 1.75

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia (1998) 1.71

Short term effects of airborne pollen concentrations on asthma epidemic. Thorax (2003) 1.68

Y-stent-assisted coil embolization of anterior circulation aneurysms using two Solitaire AB devices: a single center experience. Interv Neuroradiol (2012) 1.55

Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. J Photochem Photobiol B (2000) 1.49

Isoimmune neonatal neutropenia caused by Fc gamma RIIIb antibodies in a Spanish child. Transfusion (1995) 1.41

[Isochromosome 17q as the sole alteration in 2 patients with a myelodysplastic syndrome and its relation to myeloperoxidase activity]. Sangre (Barc) (1991) 1.40

[Retinal thrombosis in young patients. Immunological and clinical aspects]. Arch Soc Esp Oftalmol (2001) 1.40

[Relationship between T-cells subsets and prognostic markers in HIV-1-infected children]. Med Clin (Barc) (2001) 1.39

[Modification of the nutritional septicemic risk (RSN) by means of perioperative transfusion]. Nutr Hosp (1998) 1.39

[Descriptive study of first visits in a multiple sclerosis specialised unit]. Neurologia (2002) 1.39

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (2005) 1.36

Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis (2004) 1.33

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun (1999) 1.31

Hydatid cyst of the interventricular septum in a 3.5-year-old child. Ann Thorac Surg (1998) 1.27

Molecular and pathogenic characterization of Borrelia burgdorferi sensu lato isolates from Spain. J Clin Microbiol (2000) 1.25

Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency. Curr HIV Res (2010) 1.25

Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res (1998) 1.22

Dynamics of antigenemia and coproantigens during a human Fasciola hepatica outbreak. J Clin Microbiol (1998) 1.17

Life histories as adaptive strategies. J Theor Biol (1976) 1.13

The impact of a hospital and clinic-based breastfeeding promotion programme in a middle class urban environment. J Trop Pediatr (1993) 1.08

Air pollution and cardiovascular admissions association in Spain: results within the EMECAS project. J Epidemiol Community Health (2006) 1.08

[Pulmonary nocardiosis: presentation of 3 clinical cases]. Enferm Infecc Microbiol Clin (1997) 1.06

Langerhans' cell histiocytosis restricted to the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 1.06

Superior gluteal nerve: safe area in hip surgery. Surg Radiol Anat (2004) 1.05

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. Br J Dermatol (2005) 1.04

Severe Hypocalcemia due to Vitamin D Deficiency after Extended Roux-en-Y Gastric Bypass. J Obes (2011) 1.03

Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler (2008) 1.03

Fatigue in multiple sclerosis persists over time: a longitudinal study. J Neurol (2006) 1.02

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse (1998) 1.01

Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. J Clin Immunol (2003) 0.98

Subfascial and submuscular methods of temporal muscle dissection and their relationship to the frontal branch of the facial nerve. Technical note. J Neurosurg (2000) 0.97

Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol (2001) 0.96

Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study. Pediatr Res (2000) 0.95

Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma (1998) 0.95

Environmental conditions favoring bat infection with Histoplasma capsulatum in Mexican shelters. Am J Trop Med Hyg (1999) 0.94

High level expression of streptokinase in Escherichia coli. Biotechnology (N Y) (1992) 0.94

BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med (2013) 0.92

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol (2002) 0.92

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis. Mult Scler (2010) 0.91

Microsporidiosis in HIV-positive children in Madrid (Spain). J Eukaryot Microbiol (1998) 0.91

Medicinal plants used in the Barros Area, Badajoz Province, Spain. J Ethnopharmacol (1997) 0.90

Severe acute pancreatitis: treatment with somatostatin. Intensive Care Med (1998) 0.90

The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides (2005) 0.89

The effects on professional practices of a three-day course on breastfeeding. J Hum Lact (1995) 0.89

Langerhans-like cells in amphibian epidermis. J Anat (1990) 0.89

Magnetic anisotropy of a single cobalt nanocluster. Phys Rev Lett (2001) 0.88

A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections. Mycoses (2001) 0.88

Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes. Diabetes Res Clin Pract (2004) 0.87

The influence of wire positioning upon the initial stability of scaphoid fractures fixed using Kirschner wires A finite element study. Med Eng Phys (2006) 0.87

Identification of the psaA gene, coding for pneumococcal surface adhesin A, in viridans group streptococci other than Streptococcus pneumoniae. Clin Diagn Lab Immunol (2001) 0.87

A new tool for continuous detection of the presence of triatomine bugs, vectors of Chagas disease, in rural households. Medicina (B Aires) (1987) 0.87

Severe hypersensitivity reaction to minocycline. J Investig Allergol Clin Immunol (2000) 0.87

Delayed full-thickness autografting of cryopreserved avulsed skin in degloving injuries of the extremities. Plast Reconstr Surg (2001) 0.87

The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normal-overweight individuals. Obes Surg (2008) 0.87

Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia (1996) 0.87

Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus. Metabolism (1998) 0.87

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care (1999) 0.87

Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients. Metabolism (2000) 0.86

[Dexmedetomidine, a promising drug]. Rev Esp Anestesiol Reanim (2002) 0.86

Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab (2001) 0.86

Control program of hydatid disease in the province of Río Negro Argentina. 1980-1997. Bol Chil Parasitol (2001) 0.86

Selective inhibition of the sperm-specific lactate dehydrogenase isozyme-C4 by N-isopropyl oxamate. Biochim Biophys Acta (1997) 0.86

Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother (2009) 0.86

Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance. A multimethod study. Ann Hematol (1993) 0.85

Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2001) 0.85

Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells. Transplant Proc (1999) 0.85

Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J Parasitol (1998) 0.85

Fetal outcome among pregnancies in natural family planning acceptors: an international cohort study. Am J Obstet Gynecol (1991) 0.85

Nucleotide sequence and chromosomal location of L-lactate dehydrogenase gene from Streptococcus pneumoniae. Curr Microbiol (1998) 0.85

Dapsone for refractory chronic idiopathic thrombocytopenic purpura. Br J Haematol (1995) 0.85

Generating reference models for structurally complex data. Application to the stabilometry medical domain. Methods Inf Med (2013) 0.85

Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications. Diabetes Res Clin Pract (1996) 0.84

Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. Pharm Res (2008) 0.84

[Allgrove syndrome (achalasia-alacrima-adrenal gland insufficiency): report of a case]. Rev Gastroenterol Peru (1996) 0.84

[Bacteremia caused by Campylobacter jejuni resistant to nalidixic acid and fluoroquinolones]. Enferm Infecc Microbiol Clin (1993) 0.83

Disruption in cytokine and chemokine production by T-cells in vertically HIV-1-infected children. Acta Paediatr (2001) 0.83

Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes (1997) 0.83

Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. J Neurol Sci (2009) 0.83

Cladosporium macrocarpum brain abscess after endoscopic ultrasound-guided celiac plexus block. Endoscopy (2011) 0.83

Multiple myeloma of the liver presenting as nonobstructive jaundice. Am J Hematol (1996) 0.83

Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain. Epidemiol Infect (2001) 0.83

Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-infected infants. A prospective longitudinal study. Neuropediatrics (1999) 0.83

Buerger's disease and antiphospholipid antibodies in pregnancy. Ann Rheum Dis (1993) 0.82

Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy. Scand J Immunol (2000) 0.82

Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes. Transplant Proc (2010) 0.82

Recognition of a CD4+ mouse medullary thymocyte subpopulation by Amaranthus leucocarpus lectin. Immunology (1994) 0.82

Integral valorization of tagasaste (Chamaecytisus proliferus) under hydrothermal and pulp processing. Bioresour Technol (2010) 0.82

Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. A clinicopathologic study of 6 cases. Tumori (1990) 0.82

Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship. Ann Hematol (2001) 0.82

[Breast hydatid cyst. A case report]. Rev Med Chil (1997) 0.82

[Asymptomatic carriers of hydatidosis: epidemiology, diagnosis, and treatment]. Rev Panam Salud Publica (2000) 0.81

Lung lesions in bovine fetuses aborted by Brucella abortus. Can J Comp Med (1984) 0.81